Comparative efficacy and safety of anti-infective drugs for patients with mild to severe COVID-19: A systematic review and network meta-analysis of randomized controlled trials
CONCLUSION: This Network Meta-analysis suggests that Baricitinib plus Remdesivir is more effective than the other anti-infective drugs in treating patients with COVID-19 in terms of clinical recovery at 14 days, mortality and adverse events outcomes.PMID:38314347 | PMC:PMC10836338 (Source: Ethiopian Medical Journal)
Source: Ethiopian Medical Journal - February 5, 2024 Category: African Health Authors: Dejene Tolossa Debela Tsegahun Manyazewal Merga Belina Kassahun Habtamu Abebaw Fekadu Source Type: research